Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Manuscript
  • Published:

Progenitors' Cell Cycle Status in CML

Proliferating status of peripheral blood progenitor cells from patients with BCR/ABL-positive chronic myelogenous leukemia

Leukemia volume 15, pages 62–68 (2001)Cite this article

Abstract

To investigate the mechanisms behind the leukemic expansion of BCR/ABL-positive chronic myelogenous leukemia (CML), we examined the cell cycle status of hematopoietic progenitor cells from peripheral blood (PB) and bone marrow (BM) of 37 patients with newly diagnosed BCR/ABL-positive CML. We found a high proportion of 12.51 ± 1.19% of CD34+peripheral blood progenitor cells (PBPC) in S/G2M phase. Comparison of PB and BM from 19 cases revealed similar proliferation rates (10.74 ± 1.41% vs 15.97 ± 1.95%). Furthermore, even primitive CD34+/CD38− PBPC displayed high proliferation rates (17.45 ± 2.98%) in 10 cases examined. In contrast, PBPC from 11 patients with BCR/ABL-negative myeloproliferative disorders were almost noncycling (S/G2M 1.46 ± 0.47%). When matched pairs of PB and BM from six patients with BCR/ABL-negative myeloproliferative disorders were examined, only 0.89 ± 0.41% of the CD34+ PBPC, but 8.29 ± 3.13% CD34+ cells from BM were in S/G2M phase. Consistently, as compared to 19 patients with newly diagnosed BCR/ABL-positive CML, a significantly lower PB/BM ratio of CD34+ cells in S/G2M phase was found in these six patients with BCR/ABL-negative myeloprolifrative disorders. Administration of the tyrosine kinase inhibitor STI571 to 13 patients with CML in chronic phase, accelerated phase, or blast crisis lead to an inhibition of PBPC proliferation within a few days. Interestingly, CD34+ hematopoietic progenitor cells from BM remained proliferating in five cases examined, indicating that CML PBPC are more easily inhibited by STI571 as compared to CD34+ CML hematopoietic progenitor cells from BM. These data suggest that BCR/ABL leads to an enhanced cell cycle activation of CD34+ cells, which seems to be, at least in part, independent of additional factors provided by the bone marrow microenvironment.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  1. Fialkow PJ, Gartler SM, Yoshida A . Clonal origin of chronic myelocytic leukemia in man Proc Natl Acad Sci USA 1967 58: 1468–1471

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  2. Rowley JD . A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining Nature 1973 243: 290–293

    CAS  PubMed  Google Scholar 

  3. Groffen J, Stephenson JR, Heisterkamp N, De Klein A, Bartram CR, Grosveld G . Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22 Cell 1984 36: 93–99

    Article  CAS  PubMed  Google Scholar 

  4. Shtivelman E, Lifshitz B, Gale RP, Roe BA, Canaani E . Alternative splicing of RNAs transcribed from the human abl gene and from the bcr-abl fused gene Cell 1986 47: 277–284

    Article  CAS  PubMed  Google Scholar 

  5. Ben-Neriah Y, Daley G, Mes-Masson A-M, Witte O, Baltimore D . The chronic-myelogenous leukemia-specific P210 protein is the product of the bcr-abl hybrid gene Science 1986 233: 212–214

    Article  CAS  PubMed  Google Scholar 

  6. Shtivelman E, Lifshitz B, Gale RP, Canaani E . Fused transcript of abl and bcr genes in chronic myelogenous leukaemia Nature 1985 315: 550–554

    Article  CAS  PubMed  Google Scholar 

  7. Daley GQ, VanEtten RA, Baltimore D . Induction of chronic myelogenous leukemia in mice by the P210 bcr/abl gene of the Philadelphia chromosome Science 1990 247: 824–830

    Article  CAS  PubMed  Google Scholar 

  8. Heisterkamp N, Jenster G, ten Hoeve J, Zovich D, Pattengale P, Jones G . Acute leukemia in bcr/abl transgenic mice Nature 1990 344: 251–253

    Article  CAS  PubMed  Google Scholar 

  9. Bedi A, Zehnbauer BA, Barber JP, Sharkis SJ, Jones RJ . Inhibition of apoptosis by BCR-ABL in chronic myeloid leukemia Blood 1994 83: 2038–2044

    CAS  PubMed  Google Scholar 

  10. McGahon A, Bissonnette R, Schmitt M, Cotter KM, Green DR, Cotter TG . BCR-ABL maintains resistance of chronic myelogenous leukemia cells to apoptotic cell death Blood 1994 83: 1179–1187

    CAS  PubMed  Google Scholar 

  11. Traycoff CM, Halstead B, Rice S, McMahel J, Srour E, Cornetta K . Chronic myelogenous leukaemia CD34+ cells exit G0/G1 phases of the cell cycle more rapidly than normal marrow CD34+ cells Br J Haematol 1998 102: 759–767

    Article  CAS  PubMed  Google Scholar 

  12. Eaves AC, Cashman JD, Gaboury LA, Kalousek DK, Eaves CJ . Unregulated proliferation of primitive chronic myeloid leukemia progenitors in the presence of normal marrow adherent cells Proc Natl Acad Sci USA 1986 83: 5306–5310

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  13. Emanuel P, Bates L, Castleberry R, Gualtieri R, Zuckerman K . Selective hypersensitivity to granulocyte–macrophage colony-stimulating factor by juvenile chronic myeloid leukemia hematopoietic progenitors Blood 1991 77: 925–929

    CAS  PubMed  Google Scholar 

  14. Roberts AW, Metcalf D . Noncycling state of peripheral blood progenitor cells mobilized by granulocyte colony-stimulating factor and other cytokines Blood 1995 86: 1600–1605

    CAS  PubMed  Google Scholar 

  15. Lemoli RM, Tafuri A, Fortuna A, Petrucci MT, Ricciardi MR, Catani L, Rondelli D, Fogli M, Leopardi G, Ariola C, Tura S . Cycling status of CD34+ cells mobilized into peripheral blood of healthy donors by recombinant human granulocyte colony-stimulating factor Blood 1997 89: 1189–1196

    CAS  PubMed  Google Scholar 

  16. Uchida N, He D, Friera AM, Reitsma M, Sasaki D, Chen B, Tsukamoto A . The unexpected G0/G1 cell cycle status of mobilized hematopoietic stem cells from peripheral blood Blood 1997 89: 465–472

    CAS  PubMed  Google Scholar 

  17. Leitner A, Strobl H, Fischmeister G, Kurz M, Romanakis K, Haas OA, Printz D, Buchinger P, Bauer S, Gadner H, Fritsch G . Lack of DNA synthesis among CD34+ cells in cord blood and in cytokine-mobilized blood Br J Haematol 1996 92: 255–262

    Article  CAS  PubMed  Google Scholar 

  18. Jordan CT, Yamasaki G, Minamoto D . High-resolution cell cycle analysis of defined phenotypic subsets within primitive human hematopoietic cell populations Exp Hematol 1996 24: 1347–1355

    CAS  PubMed  Google Scholar 

  19. Fruehauf S, Veldwijk MR, Krämer A, Haas R, Zeller WJ . Delineation of cell cycle state and correlation to adhesion molecule expression of human CD34+ cells from steady-state bone marrow and peripheral blood mobilized following G-CSF supported chemotherapy Stem Cells 1998 16: 271–279

    Article  CAS  PubMed  Google Scholar 

  20. Thiele J, Wickenhauser C, Baldus SE, Kuemmel T, Zirbes TK, Drebber U, Wirtz R, Thiel A, Hansmann ML, Fischer R . Characterization of CD34+ human hemopoietic progenitor cells from the peripheral blood: enzyme-, carbohydrate- and immunocytochemistry, morphometry, and ultrastructure Leuk Lymphoma 1995 16: 483–491

    Article  CAS  PubMed  Google Scholar 

  21. Morrison SJ, Wright DE, Weissman IL . Cyclophosphamide/granulocyte colony-stimulating factor induces hematopoietic stem cells to proliferate prior to mobilization Proc Natl Acad Sci USA 1997 94: 1908–1913

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  22. To LB, Haylock DN, Simmons PJ, Juttner CA . The biology and clinical uses of blood stem cells Blood 1997 89: 2233–2258

    CAS  PubMed  Google Scholar 

  23. Buchdunger E, Zimmermann J, Mett H, Meyer T, Müller M, Druker BJ, Lydon NB . Inhibition of the Abl protein-tyrosine kinase in vitro and in vivo by a 2-phenylaminopyrimidine derivative Cancer Res 1996 56: 100–104

    CAS  PubMed  Google Scholar 

  24. Druker BJ, Tamura S, Buchdunger E, Ohno S, Segal GM, Fanning S, Zimmermann J, Lydon NB . Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of bcr/abl positive cells Nature Med 1996 2: 561–566

    Article  CAS  PubMed  Google Scholar 

  25. Carroll M, Ohno-Jones S, Tamura S, Buchdunger E, Zimmermann J, Lydon NB, Gilliland DG, Druker BJ . CGP57148, a tyrosine kinase inhibitor, inhibits the growth of cells expressing BCR-ABL, TEL-ABL and TEL-PDGFR fusion proteins Blood 1997 90: 4947–4952

    CAS  PubMed  Google Scholar 

  26. Druker BJ, Sawyers CL, Talpaz M, Resta D, Peng B, Ford J . Phase I trial of a specific ABL tyrosine kinase inhibitor, CGP57148, in interferon refractory chronic myelogenous leukemia patients Blood 1998 92: 252a (Abstr.)

    Google Scholar 

  27. Knaan-Shanzer S, Valerio D, van Beusechem V . Cell cycle state, response to hemopoietic growth factors and retroviral vector-mediated transduction of human hemopoietic stem cells Gene Therapy 1996 3: 323–333

    CAS  PubMed  Google Scholar 

  28. Grand FH, Marley SB, Chase A, Titley I, Healy L, Spencer A, Reiter A, Goldman JM, Gordon MY . BCR/ABL-negative progenitors are enriched in the adherent fraction of CD34+ cells circulating in the blood of chronic phase chronic myeloid leukemia patients Leukemia 1997 11: 1486–1492

    Article  CAS  PubMed  Google Scholar 

  29. Petzer AL, Eaves CJ, Lansdorp PM, Ponchio L, Barnett MJ, Eaves AC . Characterization of primitive subpopulations of normal and leukemic cells present in the blood of patients with newly diagnosed as well as established chronic myeloid leukemia Blood 1996 88: 2162–2171

    CAS  PubMed  Google Scholar 

  30. Maurer-Schultze B, Siebert M, Bassukas ID . An in vivo study on the synchronizing effect of hydroxyurea Exp Cell Res 1988 174: 230–243

    Article  CAS  PubMed  Google Scholar 

  31. Udomsadki C, Eaves CJ, Swolin B, Reid DS, Barnett MJ, Eaves AC . Rapid decline of chronic myeloid leukemic cells in long-term culture due to a defect at the leukemic stem cell level Proc Natl Acad Sci USA 1992 89: 6192–6196

    Article  Google Scholar 

  32. Matulonis U, Salgia R, Okuda K, Druker B, Griffin JD . Interleukin-3 and p210BCR/ABL activate both unique and overlapping pathways of signal transduction in a factor-dependent myeloid cell line Exp Hematol 1993 21: 1460–1466

    CAS  PubMed  Google Scholar 

  33. Laneuville P, Heisterkamp N, Groffen J . Expression of the chronic myelogenous leukaemia-associated p210BCR/ABL oncoprotein in a murine IL-3 dependent myeloid cell line Oncogene 1991 6: 275–282

    CAS  PubMed  Google Scholar 

  34. Jiang X, Lopez A, Holyoake TL, Eaves A, Eaves C . Autocrine production and action of IL-3 and G-CSF on Ph+ CD34+ cells from patients with CML Exp Hematol 1998 26: 800 (Abstr.)

    Google Scholar 

  35. Jonuleit T, Peschel C, Schwab R, van der Kuip H, Buchdunger E, Fischer T, Huber C, Aulitzky WE . Bcr-abl kinase promotes cell cycle entry of primary myeloid CML cells in the absence of growth factors Br J Haematol 1998 100: 295–303

    Article  CAS  PubMed  Google Scholar 

  36. Renshaw MW, McWhirter JR, Wang JYJ . The human leukemia oncogene bcr/abl abrogates the anchorage requirement but not the growth factor requirement for proliferation Mol Cell Biol 1995 15: 1286–1293

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  37. Lugo TG, Pendergast AM, Witte ON . Tyrosine kinase activity and transformation potency of bcr-abl gene products Science 1990 247: 1079–1082

    Article  CAS  PubMed  Google Scholar 

  38. Krämer A, Hörner S, Willer A, Frühauf S, Hochhaus A, Hallek M, Hehlmann R . Adhesion to fibronectin stimulates proliferation of wild type and bcr/abl-transfected murine hematopoietic cells Proc Natl Acad Sci USA 1999 96: 2087–2092

    Article  PubMed Central  PubMed  Google Scholar 

  39. Gordon MY, Dowding CR, Riley GP, Goldman JM, Greaves MF . Altered adhesive interactions with marrow stroma of haematopoietic progenitor cells in chronic myeloid leukaemia Nature 1987 328: 342–344

    Article  CAS  PubMed  Google Scholar 

  40. Verfaillie CM, McCarthy JB, McGlave PB . Mechanisms underlying abnormal trafficking of malignant progenitors in chronic myelogenous leukemia. Decreased adhesion to stroma and fibronectin but increased adhesion to the basement membrane components laminin and collagen type IV J Clin Invest 1992 90: 1232–1241

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  41. Terstappen LW, Huang S, Safford M, Landsdorp PM, Coken MR . Sequential generations of hematopoietic colonies derived from single nonlineage-committed CD34+/CD38− progenitor cells Blood 1991 77: 1218–1227

    CAS  PubMed  Google Scholar 

  42. Reems JA, Torok-Storb B . Cell cycle and functional differences between CD34+/CD38hi and CD34+/CD38lo human marrow cells after in vitro cytokine exposure Blood 1995 85: 1480–1487

    CAS  PubMed  Google Scholar 

  43. Hao Q-L, Shah AJ, Thiemann FT, Smogorzewska EM, Crooks GM . A functional comparison of CD34+/CD38− cells in cord blood and bone marrow Blood 1995 86: 3745–3753

    CAS  PubMed  Google Scholar 

  44. Kasper B, Fruehauf S, Schiedlmeier B, Buchdunger E, Ho AD, Zeller WJ . Favorable therapeutic index of a p210BCR-ABL specific tyrosine kinase inhibitor – activity on lineage-committed and primitive chronic myelogenous leukemia (CML) progenitors Cancer Chemother Pharmacol 1999 44: 433–438

    Article  CAS  PubMed  Google Scholar 

  45. Gambacorti-Passerini C, le Coutre P, Mologni L, Fanelli M, Bertazzoli C, Marchesi E, di Nicola M, Biondi A, Corneo GM, Belotti D, Pogliani E, Lydon NB . Inhibition of the ABL kinase activity blocks the proliferation of BCR/ABL+ leukemic cells and induces apoptosis Blood Cells Mol Dis 1997 23: 380–394

    Article  CAS  PubMed  Google Scholar 

  46. Dan S, Naito M, Tsuruo T . Selective induction of apoptosis in Philadelphia chromosome-positive chronic myelogenous leukemia cells by an inhibitor of BCR-ABL tyrosine kinase, CGP 57148 Cell Death Differ 1998 5: 710–715

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank Ms Susanne Brendel for excellent technical assistance. This work was supported by the Deutsche Krebshilfe (Grant No. 10-1179-Krl) and the Forschungsfonds, Fakultät für Klinische Medizin Mannheim, Universität Heidelberg, Germany.

Author information

Authors and Affiliations

  1. III Medizinische Klinik, Klinikum Mannheim, Universität Heidelberg, Mannheim, Germany

    A Krämer, H Löffler, J Bergmann, A Hochhaus & R Hehlmann

Authors
  1. A Krämer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H Löffler
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J Bergmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A Hochhaus
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. R Hehlmann
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Krämer, A., Löffler, H., Bergmann, J. et al. Proliferating status of peripheral blood progenitor cells from patients with BCR/ABL-positive chronic myelogenous leukemia. Leukemia 15, 62–68 (2001). https://doi.org/10.1038/sj.leu.2402005

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2402005

Keywords

This article is cited by

Search

Advanced search

Quick links